Clinical staging and prognostic markers in chronic lymphocytic leukemia

Hematol Oncol Clin North Am. 2004 Aug;18(4):795-805, vii. doi: 10.1016/j.hoc.2004.04.001.

Abstract

In this article we provide a brief review of the two staging systems in chronic lymphocytic leukemia, and we discuss the more recently identified, new prognostic markers that are of interest to clinicians and researchers in this field.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / blood
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Liver / pathology
  • Lymphocyte Count
  • Male
  • Neoplasm Staging
  • Prognosis
  • Spleen / pathology

Substances

  • Biomarkers, Tumor